Pennystockexchange.net Stocks In Action on Wednesday

** According to preliminary results, TKLC expects revenues for the third quarter fiscal 2011 to be between $103 million and $106 million with non-GAAP earnings per share to range between $0.16 and $0.20 per diluted share for the period.

TKLC connects people and devices to the mobile Internet. TKLC's portfolio's unique layer of network intelligence allows service providers to both manage and monetize the exponential growth in mobile web, video and applications traffic.

More about TKLC at www.tekelec.com.

****************

MHH, Mastech Holdings, Inc.

** On its third quarter fiscal 2011, MHH posted revenues of $23.5 million, a 24% increase year over year and gross profit totaled $4.6 million or approximately $1.0 million greater than those achieved during the same period the prior year.

MHH provides Information Technology Staffing services in the disciplines which drive today's business operations and Specialized Healthcare Staffing services to hospitals and other healthcare facilities.

More about MHH at www.mastech.com.

****************

BMTI, BioMimetic Therapeutics Inc.

** BMTI reported the Therapeutic Goods Administration has approved BMTI's medical device application for Augment Bone Graft clearing the way for commercialization of the product in Australia and its listing on the Australian Register of Therapeutic Goods.

Based on the clinical data from the North American pivotal trial and Canadian registration trial evaluating Augment Bone Graft, the product has been approved in Australia for use as an alternative to autograft, the current gold standard in bone grafting, in hindfoot and ankle fusion procedures.

BMTI is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedics, sports medicine and spine applications.

More about BMTI at www.biomimetics.com